Evidence map›Paper›PMID 18754742›Full record

ArticleThe Journal of infectious diseases2008

Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.

Fumiko Obata, Koujiro Tohyama, Adrian D Bonev, Glynis L Kolling, Tiffany R Keepers, Lisa K Gross, Mark T Nelson, Shigehiro Sato, Tom G Obrig

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Shiga Toxin Induces ApoptosisJournal of microbiology and biotechnology · 2026
    Article
  3. Shiga toxin-producingMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Shiga Toxin, Stx2e, Influences the Activity of Porcine Lymphocytes In Vitro.International journal of molecular sciences · 2023
    Article
  12. Review
  13. Article
  14. Role of Globotriaosylceramide in Physiology and Pathology.Frontiers in molecular biosciences · 2022
    Review
  15. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.Frontiers in cellular and infection microbiology · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Fumiko ObataDepartments of Medicine (Nephrology) and Microbiology, University of Virginia Health Science Center, Charlottesville, VA, USA.
Koujiro Tohyama
Adrian D Bonev
Glynis L Kolling
Tiffany R Keepers
Lisa K Gross
Mark T Nelson
Shigehiro Sato
Tom G Obrig
University of Virginia · USIwate Medical University · JPUniversity of Vermont · US

Funding

VASCULAR DYSFUNCTION AS AN ETIOLOGY OF HYPERTENSIONP01HL077378 · NHLBI · TUFTS MEDICAL CENTER · PI MENDELSOHN, MICHAEL E · 2004 to 2008
$11.0M
Global Biothreats Training ProgramT32AI055432 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CRISS, ALISON K, PETRI, WILLIAM A · 2003 to 2022
$4.0M
REGULATION OF CEREBRAL ARTERY DILATIONR01HL044455 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI NELSON, MARK T · 1991 to 2010
$3.9M
SHIGA TOXIN MODE OF ACTION IN BACTERIAL DISEASESR01AI024431 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OBRIG, TOM G · 1989 to 2007
$2.9M
SHIGA TOXIN MODE OF ACTION IN BACTERIAL DISEASESR22AI024431 · NIAID · ALBANY MEDICAL COLLEGE · PI OBRIG, TOM G · 1987 to 1989
–
NHLBI NIH HHS HL 44455NHLBI NIH HHS HL44455NHLBI NIH HHS HL77378NHLBI NIH HHS R01 HL044455NIAID NIH HHS AI024431NIAID NIH HHS R01 AI024431NIAID NIH HHS T32 AI055432
6 · The paper itself

Abstract

Affinity-purified Shiga toxin (Stx) 2 given intraperitoneally to mice caused weight loss and hind-limb paralysis followed by death. Globotriaosylceramide (Gb(3)), the receptor for Stx2, was localized to neurons of the central nervous system (CNS) of normal mice. Gb3 was not found in astrocytes or endothelial cells of the CNS. In human cadaver CNS, we found Gb(3) in neurons and endothelial cells. Mouse Gb(3) localization was confirmed by immunoelectron microscopy. In Stx2-exposed mice, anti-Stx2-gold immunoreaction was positive in neurons. During paralysis, after Stx2 injection, multiple glial nuclei were observed surrounding motoneurons by electron microscopy. Also revealed was a lamellipodia-like process physically inhibiting the synaptic connection of motoneurons. Ca2+ imaging of cerebral astrocytic end-feet in Stx2-treated mouse brains suggested that the toxin increased neurotransmitter release from neurons. In this article, we propose that the neuron is a primary target of Stx2, affecting neuronal function and leading to paralysis.

Indexed as

AnimalsBiological TransportCalciumCentral Nervous SystemFemaleFluorescent Antibody TechniqueGene Expression RegulationHumansMaleMiceMotor NeuronsNeurogliaNeuronsShiga Toxin 2Specific Pathogen-Free OrganismsTrihexosylceramidesCalciumglobotriaosylceramideShiga Toxin 2Trihexosylceramides

Identifiers

PMID18754742
PMCPMC2684825
OpenAlexW2147310858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.